Blockade of CCR5+ T Cell Accumulation in the Tumor Microenvironment Optimizes Anti-TGF-β/PD-L1 Bispecific Antibody.
Yi M, Li T, Niu M, Wu Y, Zhao B, Shen Z, Hu S, Zhang C, Zhang X, Zhang J, Yan Y, Zhou P, Chu Q, Dai Z, Wu K.
Yi M, et al. Among authors: zhao b.
Adv Sci (Weinh). 2024 Sep 20:e2408598. doi: 10.1002/advs.202408598. Online ahead of print.
Adv Sci (Weinh). 2024.
PMID: 39303165